Table 3 ACS administration characteristics in neonatal deaths <28 days compared to survivors at 28 days by prematurity among those identified by the intervention who received steroids
Characteristic- n (%) | Preterm | Term | Totalb | ||||||
|---|---|---|---|---|---|---|---|---|---|
ND <28d | LB, alive at 28d | Pa | ND < 28d | LB, alive at 28d | Pa | ND < 28d | LB, alive at 28d | Pa | |
Women, N | 204 | 1639 | 100 | 3672 | 304 | 5311 | |||
Time since 1st dose to delivery | 203 | 1633 | * | 98 | 3597 | * | 301 | 5230 | ** |
Less Than 2 Days | 101 (49.8) | 765 (46.8) | 16 (16.3) | 411 (11.4) | 117 (38.9) | 1176 (22.5) | |||
2–7 Days | 48 (23.6) | 263 (16.1) | 10 (10.2) | 232 (6.4) | 58 (19.3) | 495 (9.5) | |||
8–30 Days | 26 (12.8) | 279 (17.1) | 14 (14.3) | 808 (22.5) | 40 (13.3) | 1087 (20.8) | |||
More than 1 month | 28 (13.8) | 326 (20.0) | 58 (59.2) | 2146 (59.7) | 86 (28.6) | 2472 (47.3) | |||
Doses of 6 mg Dexamethasone Received | 193 | 1569 | 99 | 3626 | 292 | 5195 | ** | ||
1 dose | 82 (42.5) | 622 (39.6) | 13 (13.1) | 464 (12.8) | 95 (32.5) | 1086 (20.9) | |||
2 doses | 16 (8.3) | 120 (7.6) | 7 (7.1) | 141 (3.9) | 23 (7.9) | 261 (5.0) | |||
3 doses | 7 (3.6) | 64 (4.1) | 0 (0.0) | 68 (1.9) | 7 (2.4) | 132 (2.5) | |||
4 doses | 88 (45.6) | 763 (48.6) | 79 (79.8) | 2953 (81.4) | 167 (57.2) | 3716 (71.5) | |||
Maternal conditions at moment of receiving corticosteroids | 204 | 1639 | 100 | 3672 | 304 | 5311 | |||
Signs of preterm labor | 139 (68.1) | 1208 (73.7) | * | 74 (74.0) | 2910 (79.2) | * | 213 (70.1) | 4118 (77.5) | * |
PPROM | 45 (22.1) | 390 (23.8) | 16 (16.0) | 627 (17.1) | 61 (20.1) | 1017 (19.1) | |||
Hemorrhage | 31 (15.2) | 128 (7.8) | ** | 4 (4.0) | 191 (5.2) | 35 (11.5) | 319 (6.0) | ** | |
Hypertension | 32 (15.7) | 233 (14.2) | 24 (24.0) | 531 (14.5) | ** | 56 (18.4) | 764 (14.4) | ||
Other | 5 (2.5) | 39 (2.4) | 1 (1.0) | 128 (3.5) | 6 (2.0) | 167 (3.1) | |||
Where was the woman first identified? | 204 | 1639 | 100 | 3672 | 304 | 5311 | |||
Community level | 109 (53.4) | 897 (54.7) | 72 (72.0) | 2322 (63.2) | 181 (59.5) | 3219 (60.6) | |||
Primary health care | 69 (33.8) | 463 (28.2) | 22 (22.0) | 934 (25.4) | 91 (29.9) | 1397 (26.3) | |||
Hospital | 26 (12.7) | 279 (17.0) | 6 (6.0) | 416 (11.3) | 32 (10.5) | 695 (13.1) | |||
Where was the injection given, N | 204 | 1639 | 100 | 3672 | 304 | 5311 | |||
1st dose | 204 | 1639 | 100 | 3672 | 304 | 5311 | |||
Home | 32 (15.7) | 280 (17.1) | 19 (19.0) | 820 (22.3) | 51 (16.8) | 1100 (20.7) | |||
Health Center | 139 (68.1) | 950 (58.0) | 72 (72.0) | 2332 (63.5) | 211 (69.4) | 3282 (61.8) | |||
Hospital | 33 (16.2) | 409 (25.0) | 9 (9.0) | 520 (14.2) | 42 (13.8) | 929 (17.5) | |||
2nd dose | 118 | 974 | 86 | 3198 | 204 | 4172 | |||
Home | 31 (26.3) | 317 (32.5) | 30 (34.9) | 1184 (37.0) | 61 (29.9) | 1501 (36.0) | |||
Health Center | 50 (42.4) | 401 (41.2) | 48 (55.8) | 1523 (47.6) | 98 (48.0) | 1924 (46.1) | |||
Hospital | 37 (31.4) | 256 (26.3) | 8 (9.3) | 491 (15.4) | 45 (22.1) | 747 (17.9) | |||